Yahoo Poland Wyszukiwanie w Internecie

Search results

  1. 12 cze 2023 · Hepatocellular carcinoma is the fifth leading cause of cancer worldwide and the second cause of cancer deaths in men. Risk factors for HCC include chronic hepatitis B virus infection, chronic hepatitis C virus infection, alcohol abuse, and non-alcoholic fatty liver disease.

  2. Hepatocellular carcinoma (HCC) is the fourth-leading cause of cancer-related mortality worldwide and the fastest-rising cause of cancer-related death in the United States. Given the strong association between tumor stage and prognosis, HCC surveillance is recommended in high-risk patients, including patients with cirrhosis from any etiology.

  3. HBV DNA integrates into the host cellular genome in the majority of cases of chronic hepatitis B (CHB) and induces genetic damage. DNA integration in nontu-moral cells in patients with HCC suggests that genomic integration and damage precede the development of tumor.

  4. cellular carcinoma represents about 90% of primary liver can-cers and constitutes a major global health problem. The following Clinical Practice Guidelines will give up-to-date advice for the clinical management of patients with hepatocel-lular carcinoma, as well as providing an in-depth review of all

  5. 31 sty 2019 · Hepatocellular carcinoma: ESMO Clinical Practice † Guidelines for diagnosis, treatment and follow-up. *Correspondence to: ESMO Guidelines Committee, ESMO Head Office, Via Ginevra 4, 6900 Lugano, Switzerland. E-mail: clinicalguidelines@esmo.org. †Approved by the ESMO Guidelines Committee: August 2018.

  6. 6 wrz 2022 · Hepatocellular carcinoma is one of the most common cancers worldwide and represents a major global health-care challenge. Although viral hepatitis and alcohol remain important risk factors, non-alcoholic fatty liver disease is rapidly becoming a dominant cause of hepatocellular carcinoma.

  7. 30 maj 2023 · This article summarises expert discussion on the management of patients with hepatocellular carcinoma (HCC), which took place during the 24th World Gastrointestinal Cancer Congress (WGICC) in Barcelona, July 2022.

  1. Ludzie szukają również